TY - JOUR KW - Histocompatibility Antigens Class II KW - HLA-DR Antigens KW - Humans KW - Immunity, Cellular KW - leprosy KW - Levamisole KW - Lymphocyte Cooperation KW - Macrophage Activation KW - Macrophages KW - Mycobacterium leprae KW - Receptors, Fc KW - Rosette Formation AU - Birdi T J AU - Mistry N F AU - Mahadevan P R AU - Antia N H AB -

Our previous studies have demonstrated a defective macrophage response to M. leprae in lepromatous leprosy patients. In the present study we report the restoration of Fc receptor and HLA-DR antigen expression as well as antigen specific macrophage-lymphocyte interaction on treatment with levamisole in vitro. These results indicate that levamisole activates the macrophages which in turn results in an improved cell mediated immune response in lepromatous leprosy. This may also be applicable in other disease situations.

BT - Journal of clinical & laboratory immunology C1 - http://www.ncbi.nlm.nih.gov/pubmed/6374154?dopt=Abstract DA - 1984 Feb IS - 2 J2 - J Clin Lab Immunol LA - eng N2 -

Our previous studies have demonstrated a defective macrophage response to M. leprae in lepromatous leprosy patients. In the present study we report the restoration of Fc receptor and HLA-DR antigen expression as well as antigen specific macrophage-lymphocyte interaction on treatment with levamisole in vitro. These results indicate that levamisole activates the macrophages which in turn results in an improved cell mediated immune response in lepromatous leprosy. This may also be applicable in other disease situations.

PY - 1984 SP - 93 EP - 6 T2 - Journal of clinical & laboratory immunology TI - In vitro studies on the effect of levamisole in lepromatous leprosy. VL - 13 SN - 0141-2760 ER -